Advancing nasal formulation characterization: Considerations toward a robust and precise method to determine the mass fraction below 10 μm in nasal products-Reference-Cited by-同舟云学术

Advancing nasal formulation characterization: Considerations toward a robust and precise method to determine the mass fraction below 10 μm in nasal products

Published:2024-09-03 Issue: Volume: Page:1-13
ISSN:0278-6826
Container-title:Aerosol Science and Technology
language:en
Short-container-title:Aerosol Science and Technology

Author:

Baltz Niklas¹^ORCID,Svensson Jan Olof²³^ORCID,Skogevall Marcus³,Ohlsson Ann⁴,Svensson Mårten⁴,Scherließ Regina¹^ORCID

Affiliation:

1. Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany

2. Department of Chemistry and Biochemistry, Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden

3. AstraZeneca, Gothenburg, Sweden

4. Emmace, Lund, Sweden

Funder

European Pharmaceutical Aerosol Group

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/02786826.2024.2394593

Reference22 articles.

1. In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas

2. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery

3. Measurement of Drug in Small Particles from Aqueous Nasal Sprays by Andersen Cascade Impactor

4. Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)

5. EMA. 2006. Guideline on the pharmaceutical quality of inhalation and nasal products. EMA. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-quality-inhalation-and-nasal-products_en.pdf